chidamide Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Hunan Cancer Hospital (1)
Ruijin Hospital (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadlymphoma

I am/have/hadrenal function

I am/have/hadelectrocardiogram

I am/have/hadct scan

I am/have/hadcancer therapy

I am/have/hadbiological therapy

I am/have/hadmeasurable disease

I am/have/hadperipheral t-cell lymphoma

I am/have/hadserum bilirubin

I am/have/hadpositron emission tomography

I am/have/hadneutrophil count

I am/have/hadcancer

I am/have/hadt-cell lymphoma

I am/have/hadfrontal sinus

I am/have/hadhepatitis c

I am/have/hadpet/ct scan

added new label for I am/have/had

more

I am looking for

I am looking fortucidinostat

I am looking forchidamide

I am looking forpeg-asparaginase

I am looking forglucocorticoids

I am looking forazacitidine

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

This prospective, open-label, single-arm study will evaluate the efficacy and safety of azacitidine in combination with chidamide in treatment of newly diagnosed peripheral T-cell lymphoma unfit for conventional chemotherapy.

peripheral t-cell lymphoma

measurable disease

lymphoma

chidamide

t-cell lymphoma

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

This prospective pilot study to evaluate the efficacy and safety of the anti-PD-1 antibody combine with Peg-asparaginase and Chidamide regimen for stage IE and IIE ENKTL.

measurable disease

serum bilirubin

positron emission tomography

renal function

neutrophil count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.